What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes? (Therapeutic Advances in Musculoskeletal Disease, 2024)

(untitled) - Taylor, PC; Feist, E; Pope, JE; Nash, P; Sibilia, J; Caporali, R; Balsa, A